Placulumab

Placulumab
Monoclonal antibody
Type ?
Source Human
Target TNF
Clinical data
ATC code none
Identifiers
CAS Number 945781-29-3
ChemSpider none
Chemical and physical data
Formula C3404H5262N902O1036S22
Molar mass 78.7 kg/mol

Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.[1]

This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.

References

  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Placulumab, American Medical Association.


This article is issued from Wikipedia - version of the 2/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.